/**
 * Copyright (C) 2020 New York City Department of Health and Mental Hygiene, Bureau of Immunization
 * Contributions by HLN Consulting, LLC
 *
 * This program is free software: you can redistribute it and/or modify it under the terms of the GNU
 * Lesser General Public License as published by the Free Software Foundation, either version 3 of the
 * License, or (at your option) any later version. You should have received a copy of the GNU Lesser
 * General Public License along with this program. If not, see <http://www.gnu.org/licenses/> for more
 * details.
 *
 * The above-named contributors (HLN Consulting, LLC) are also licensed by the New York City
 * Department of Health and Mental Hygiene, Bureau of Immunization to have (without restriction,
 * limitation, and warranty) complete irrevocable access and rights to this project.
 *
 * This program is distributed in the hope that it will be useful, but WITHOUT ANY WARRANTY; THE
 *
 * SOFTWARE IS PROVIDED "AS IS" WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING,
 * BUT NOT LIMITED TO, WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND
 * NONINFRINGEMENT. IN NO EVENT SHALL THE COPYRIGHT HOLDERS, IF ANY, OR DEVELOPERS BE LIABLE FOR
 * ANY CLAIM, DAMAGES, OR OTHER LIABILITY OF ANY KIND, ARISING FROM, OUT OF, OR IN CONNECTION WITH
 * THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE SOFTWARE.
 *
 * For more information about this software, see http://www.hln.com/ice or send
 * correspondence to ice@hln.com.
 */

package knowledgeModule.gov.nyc.cir.ice

import java.util.List
import java.util.Set
import org.opencds.vmr.v1_0.internal.EvalTime
import org.opencds.vmr.v1_0.internal.EvaluatedPerson
import org.cdsframework.ice.service.DiseaseImmunity
import org.cdsframework.ice.service.DoseRule
import org.cdsframework.ice.service.DoseStatus
import org.cdsframework.ice.service.ICEFactTypeFinding
import org.cdsframework.ice.service.ICELogicHelper
import org.cdsframework.ice.service.RecommendationStatus
import org.cdsframework.ice.service.SeriesRules
import org.cdsframework.ice.supportingdatatmp.SupportedFactConcept
import org.cdsframework.ice.service.TargetDose
import org.cdsframework.ice.service.TargetSeries
import org.cdsframework.ice.util.TimePeriod
import org.cdsframework.ice.util.TimePeriod.DurationType
import org.cdsframework.ice.service.Vaccine

expander ../../knowledgeCommon/org.cdsframework.ice/org.cdsframework^ICE^1.0.0.dsl

global java.util.Date evalTime


// CVX 164 (Meningococcal B, NOS) is not listed in the table above because it does not count toward the completion of the Meningococcal B series. CVX 164 is categorized in the "Other Vaccine Group". 
// (Reference the General Rules for more details.) If CVX 164 is reported, then evaluate as EVALUATION_NOT_STARTED (new evaluation code) and the reason code is VACCINE_NOT_SUPPORTED (new reason code). Ignore
// he reported CVX 164 when determining the recommended vaccine and calculating the recommended due date for the next target dose. 
//
// AI: Confirm if this should be displayed in the Meningococcal B vaccine group, or the Other Vaccine Group


/*************************************************************************************************************************************************************************************
COVID-19 Pfizer 2-dose Series specific rules
*************************************************************************************************************************************************************************************/

// If non-CVX 208 vaccine is reported in the Pfizer 2-dose series, allow the vaccine to be evaluated as Valid.
rule "COVID-19 / Pfizer 2-dose series: Evaluate non-CVX 208 shot as VALID"
	dialect "mvel"
	agenda-group "HistoryEvaluation^customEvaluationRule"
	activation-group "allowableVaccineCheck"
	when
		There is an administered shot $currentShot that needs to be evaluated
			- the shot belongs to the Vaccine Group "VACCINE_GROUP_CONCEPT.850" and the Series with name "COVID19Pfizer2DoseSeries"
			- the vaccine administered is not "ICE208"
			- the series that the shot belongs to is not complete
			- make note of the associated series as $targetSeries
	then
		Include the reason for shot $currentShot Valid
		Record that this dose rule was Processed for the TargetDose $currentShot
		Log that this dose rule fired for the dose $currentShot in the Series $targetSeries
end

/*************************************************************************************************************************************************************************************
COVID-19 Pfizer 2-dose Series specific END
*************************************************************************************************************************************************************************************/


/*************************************************************************************************************************************************************************************
COVID-19 Moderna 2-dose Series specific
*************************************************************************************************************************************************************************************/

// If non-CVX 207 vaccine is reported in Moderna 2-dose series, allow the vaccine to be evaluated as Valid.
rule "COVID-19 / Moderna 2-dose series : Evaluate non-CVX 207 as VALID"
	dialect "mvel"
	agenda-group "HistoryEvaluation^customEvaluationRule"
	activation-group "allowableVaccineCheck"
	when
		There is an administered shot $currentShot that needs to be evaluated
			- the shot belongs to the Vaccine Group "VACCINE_GROUP_CONCEPT.850" and the Series with name "COVID19Moderna2DoseSeries"
			- the vaccine administered is not "ICE207"
			- the series that the shot belongs to is not complete
			- make note of the associated series as $targetSeries
	then
		Include the reason for shot $currentShot Valid
		Record that this dose rule was Processed for the TargetDose $currentShot
		Log that this dose rule fired for the dose $currentShot in the Series $targetSeries
end

/*************************************************************************************************************************************************************************************
COVID-19 Moderna 2-dose Series specific END
*************************************************************************************************************************************************************************************/
